Akinda screens Halozyme Therapeutics, Inc. (HALO) using Islamic finance criteria. The current classification is Not Halal. Screening is informational and not a fatwa; consult a qualified scholar for personal guidance.

Whether a Muslim may invest depends on your school of thought and the stock's Shariah classification. On Akinda, Halozyme Therapeutics, Inc. (HALO) is currently labeled Not Halal. Always verify with your own research and advisors.

You can view Halozyme Therapeutics, Inc.'s Shariah status on this symbol page (ticker HALO), in the header, and on the Summary tab. The Akinda app shows the same screening when you search for HALO.

Halozyme Therapeutics, Inc. (HALO) receives its label from Akinda's methodology: business activity (non-permissible revenue) and financial ratios (interest-bearing debt and assets) are compared to published thresholds. The result Not Halal reflects those screens at the time of the latest data.

Yes. Halozyme Therapeutics, Inc. (HALO) can move from Halal to Doubtful or Not halal if revenue mix, debt, or impermissible income crosses Akinda's limits. Check HALO periodically—Akinda updates results when new filings arrive.